Bank of New York Mellon’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-88,504
| Closed | -$85K | – | 4467 |
|
|
2023
Q2 | $85K | Sell |
88,504
-75
| -0.1% | -$74 | ﹤0.01% | 4105 |
|
|
2023
Q1 | $66.4K | Hold |
88,579
| – | – | ﹤0.01% | 4138 |
|
|
2022
Q4 | $32.6K | Sell |
88,579
-83
| -0.1% | -$35 | ﹤0.01% | 4295 |
|
|
2022
Q3 | $38K | Buy |
88,662
+911
| +1% | +$895 | ﹤0.01% | 4367 |
|
|
2022
Q2 | $69K | Sell |
87,751
-408,399
| -82% | -$360K | ﹤0.01% | 4299 |
|
|
2022
Q1 | $640K | Sell |
496,150
-851,503
| -63% | -$784K | ﹤0.01% | 3567 |
|
|
2021
Q4 | $1.71M | Sell |
1,347,653
-26,035
| -2% | -$46.6K | ﹤0.01% | 3083 |
|
|
2021
Q3 | $2.99M | Buy |
1,373,688
+60,669
| +5% | +$166K | ﹤0.01% | 2766 |
|
|
2021
Q2 | $4.92M | Sell |
1,313,019
-140,871
| -10% | -$490K | ﹤0.01% | 2492 |
|
|
2021
Q1 | $4.74M | Sell |
1,453,890
-61,448
| -4% | -$220K | ﹤0.01% | 2468 |
|
|
2020
Q4 | $5.17M | Buy |
1,515,338
+14,652
| +1% | +$60.3K | ﹤0.01% | 2342 |
|
|
2020
Q3 | $6.12M | Buy |
1,500,686
+246,837
| +20% | +$938K | ﹤0.01% | 2114 |
|
|
2020
Q2 | $4.24M | Buy |
1,253,849
+65,086
| +5% | +$190K | ﹤0.01% | 2282 |
|
|
2020
Q1 | $2.77M | Sell |
1,188,763
-73,255
| -6% | -$201K | ﹤0.01% | 2375 |
|
|
2019
Q4 | $4.59M | Buy |
1,262,018
+45,687
| +4% | +$369K | ﹤0.01% | 2385 |
|
|
2019
Q3 | $10.1M | Buy |
1,216,331
+5,344
| +0.4% | +$43.2K | ﹤0.01% | 1930 |
|
|
2019
Q2 | $10.4M | Buy |
1,210,987
+21,727
| +2% | +$194K | ﹤0.01% | 1941 |
|
|
2019
Q1 | $12.7M | Buy |
1,189,260
+34,599
| +3% | +$371K | ﹤0.01% | 1835 |
|
|
2018
Q4 | $10.1M | Sell |
1,154,661
-1,424
| -0.1% | -$18.1K | ﹤0.01% | 1890 |
|
|
2018
Q3 | $19.4M | Buy |
1,156,085
+50,157
| +5% | +$1.09M | 0.01% | 1643 |
|
|
2018
Q2 | $23.2M | Buy |
1,105,928
+34,070
| +3% | +$631K | 0.01% | 1512 |
|
|
2018
Q1 | $17.2M | Buy |
1,071,858
+22,968
| +2% | +$455K | ﹤0.01% | 1664 |
|
|
2017
Q4 | $19.9M | Buy |
1,048,890
+129,556
| +14% | +$2.35M | 0.01% | 1563 |
|
|
2017
Q3 | $12.9M | Buy |
919,334
+25,642
| +3% | +$232K | ﹤0.01% | 1852 |
|
|
2017
Q2 | $6.66M | Sell |
893,692
-64,314
| -7% | -$420K | ﹤0.01% | 2184 |
|
|
2017
Q1 | $6.23M | Buy |
958,006
+32,477
| +4% | +$182K | ﹤0.01% | 2218 |
|
|
2016
Q4 | $4.1M | Buy |
925,529
+76,194
| +9% | +$320K | ﹤0.01% | 2429 |
|
|
2016
Q3 | $3.97M | Buy |
849,335
+76,112
| +10% | +$451K | ﹤0.01% | 2350 |
|
|
2016
Q2 | $5.08M | Sell |
773,223
-29,088
| -4% | -$206K | ﹤0.01% | 2204 |
|
|
2016
Q1 | $5.1M | Buy |
802,311
+13,291
| +2% | +$68.2K | ﹤0.01% | 2171 |
|
|
2015
Q4 | $4.76M | Sell |
789,020
-7,046
| -0.9% | -$40.3K | ﹤0.01% | 2242 |
|
|
2015
Q3 | $4.76M | Buy |
796,066
+99,711
| +14% | +$692K | ﹤0.01% | 2259 |
|
|
2015
Q2 | $4.76M | Buy |
696,355
+96,132
| +16% | +$610K | ﹤0.01% | 2382 |
|
|
2015
Q1 | $3.64M | Buy |
600,223
+14,180
| +2% | +$94.3K | ﹤0.01% | 2485 |
|
|
2014
Q4 | $4.06M | Sell |
586,043
-10,217
| -2% | -$75.1K | ﹤0.01% | 2426 |
|
|
2014
Q3 | $4.85M | Buy |
596,260
+31,336
| +6% | +$245K | ﹤0.01% | 2334 |
|
|
2014
Q2 | $4.59M | Buy |
564,924
+9,659
| +2% | +$73.3K | ﹤0.01% | 2371 |
|
|
2014
Q1 | $4.35M | Sell |
555,265
-12,222
| -2% | -$103K | ﹤0.01% | 2388 |
|
|
2013
Q4 | $5.02M | Sell |
567,487
-45,379
| -7% | -$405K | ﹤0.01% | 2290 |
|
|
2013
Q3 | $5.14M | Buy |
612,866
+21,841
| +4% | +$177K | ﹤0.01% | 2226 |
|
|
2013
Q2 | $4.41M | Buy |
+591,025
| New | +$4.53M | ﹤0.01% | 2259 |
|
Bank of New York Mellon's SPPI Position: Q3 2023 in Review
Bank of New York Mellon sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 88,504 shares — an estimated $85K sold.
Bank of New York Mellon first reported a position in SPPI in Q2 2013 and held it in 41 quarters. The position peaked at $23.2M in Q2 2018. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- Bank of New York Mellon reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- Bank of New York Mellon sold 88,504 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $85K.
- Bank of New York Mellon first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 41 quarters.
- Bank of New York Mellon's Spectrum Pharmaceuticals Inc position peaked at $23.2M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on Bank of New York Mellon's 13F filing for Q3 2023, filed 24 Oct 2023.